OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

The Food and Drug Administration, through the Office of Minority Health and Health Equity, is offering funding to support research and implementation of innovative, community-based strategies aimed at increasing public awareness and education about the health risks associated with over-the-counter skin lightening products containing hydroquinone and/or mercury. This initiative seeks to strengthen the scientific foundation for public health messaging and outreach, with a focus on engaging stakeholders and partners to expand education efforts among populations most affected by the use of these products. The goal is to reduce unsafe usage through targeted, culturally competent campaigns that promote informed decision-making. This funding opportunity is structured as a U01 grant and explicitly prohibits clinical trials. It is open to organizations capable of designing and executing effective outreach programs grounded in community needs and evidence-based approaches. The application process is managed through Grants.gov with Terrin Brown listed as the primary point of contact for inquiries. The opportunity was posted on December 12, 2023, and seeks to enhance the FDA’s capacity to address health equity concerns related to skin lightening product safety through collaborative, non-clinical public health interventions.